Ryan Specialty Holdings, Inc. (RYAN)
| Market Cap | 12.14B -13.7% |
| Revenue (ttm) | 3.20B +10.1% |
| Net Income | 104.62M +51.2% |
| EPS | 0.79 |
| Shares Out | 251.58M |
| PE Ratio | 61.45 |
| Forward PE | 20.38 |
| Dividend | $0.52 (1.08%) |
| Ex-Dividend Date | Nov 10, 2026 |
| Volume | 2,852,881 |
| Open | 48.18 |
| Previous Close | 47.54 |
| Day's Range | 47.20 - 48.69 |
| 52-Week Range | 29.28 - 58.94 |
| Beta | 0.54 |
| Analysts | Buy |
| Price Target | 49.66 (+2.9%) |
| Earnings Date | Oct 29, 2026 |
About RYAN
Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, Singapore, and internationally. The company offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter or a program administrator with delegated authority from insurance carriers. It serves commercial, industrial, institutional, indivi... [Read more]
Financial Performance
In 2025, Ryan Specialty Holdings's revenue was $2.99 billion, an increase of 21.95% compared to the previous year's $2.46 billion. Earnings were $63.40 million, a decrease of -33.03%.
Financial StatementsAnalyst Summary
According to 19 analysts, the average rating for RYAN stock is "Buy." The 12-month stock price target is $49.66, which is an increase of 2.90% from the latest price.
News
Ryan Specialty price target lowered to $52 from $55 at UBS
UBS lowered the firm’s price target on Ryan Specialty (RYAN) to $52 from $55 and keeps a Buy rating on the shares.
Ryan Specialty Holdings Earnings Call Transcript: Q3 2026
Q3 revenue grew 4.7% to $790M and adjusted EPS rose 8.5% to $0.51 despite intensifying pricing competition. FY organic growth guidance remains toward the high end of mid-single digits, while the expected adjusted margin decline narrowed to ~50 bps.
Ryan Specialty Holdings Earnings release: Q3 2026
Ryan Specialty Holdings released its Q3 2026 earnings on October 29, 2026, summarizing the period's financial results.
Ryan Specialty Holdings Quarterly report: Q3 2026
Ryan Specialty Holdings has published its Q3 2026 quarterly earnings report on October 29, 2026.
Ryan Specialty Reports Third Quarter 2026 Results
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”), a leading international specialty insurance firm, today announced results for the third quarte...
Ryan Specialty Holdings Slides: Investor presentation
Ryan Specialty Holdings has posted slides in relation to its latest quarterly earnings report, which was published on October 29, 2026.
Ryan Specialty price target lowered to $67 from $72 at BofA
BofA analyst Joshua Shanker lowered the firm’s price target on Ryan Specialty (RYAN) to $67 from $72 and keeps a Buy rating on the shares. The firm, which adjusted estimates…
Ryan Specialty price target lowered to $41 from $43 at Wells Fargo
Wells Fargo lowered the firm’s price target on Ryan Specialty (RYAN) to $41 from $43 and keeps an Equal Weight rating on the shares. The firm also launched a Bearish…
Ryan Specialty price target lowered to $49 from $54 at Keefe Bruyette
Keefe Bruyette lowered the firm’s price target on Ryan Specialty (RYAN) to $49 from $54 and keeps an Outperform rating on the shares.
Ryan Specialty price target lowered to $40 from $43 at Mizuho
Mizuho analyst Yaron Kinar lowered the firm’s price target on Ryan Specialty (RYAN) to $40 from $43 and keeps a Neutral rating on the shares. The firm adjusted targets in…
Ryan Specialty price target lowered to $40 from $48 at Piper Sandler
Piper Sandler analyst Paul Newsome lowered the firm’s price target on Ryan Specialty (RYAN) to $40 from $48 and keeps a Neutral rating on the shares. Piper’s quarter end channel…
Ryan Specialty to Announce Third Quarter 2026 Financial Results on Thursday, October 29, 2026
CHICAGO--(BUSINESS WIRE)--Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty”), a leading international specialty insurance firm, today announced it will release its Third Quarter 2026 financ...
Ryan Specialty price target lowered to $43 from $48 at Mizuho
Mizuho lowered the firm’s price target on Ryan Specialty (RYAN) to $43 from $48 and keeps a Neutral rating on the shares. The firm adjusted targets in the property and…
Ryan Specialty price target raised to $50 from $48 at Morgan Stanley
Morgan Stanley analyst Bob Huang raised the firm’s price target on Ryan Specialty (RYAN) to $50 from $48 and keeps an Overweight rating on the shares. The firm updated models…
Ryan Specialty price target raised to $55 from $50 at UBS
UBS raised the firm’s price target on Ryan Specialty (RYAN) to $55 from $50 and keeps a Buy rating on the shares.
Ryan Specialty price target raised to $48 from $42 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $42 and keeps an Overweight rating on the shares.
Ryan Specialty price target raised to $45 from $39 at JPMorgan
JPMorgan raised the firm’s price target on Ryan Specialty (RYAN) to $45 from $39 and keeps an Underweight rating on the shares. The company reported a strong quarter but the…
Ryan Specialty price target raised to $53.50 from $50 at Citi
Citi raised the firm’s price target on Ryan Specialty (RYAN) to $53.50 from $50 and keeps a Buy rating on the shares.
Ryan Specialty price target raised to $55 from $45 at RBC Capital
RBC Capital raised the firm’s price target on Ryan Specialty (RYAN) to $55 from $45 and keeps an Outperform rating on the shares after its Q2 earnings beat. The firm…
Ryan Specialty price target raised to $48 from $44 at Piper Sandler
Piper Sandler raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $44 and keeps a Neutral rating on the shares following quarterly results. The firm says that…
Ryan Specialty price target raised to $48 from $39 at Mizuho
Mizuho raised the firm’s price target on Ryan Specialty (RYAN) to $48 from $39 and keeps a Neutral rating on the shares.
Ryan Specialty price target raised to $45 from $40 at Goldman Sachs
Goldman Sachs analyst Robert Cox raised the firm’s price target on Ryan Specialty (RYAN) to $45 from $40 and keeps a Neutral rating on the shares. Investors are expected to…
Ryan Specialty price target raised to $54 from $48 at Keefe Bruyette
Keefe Bruyette raised the firm’s price target on Ryan Specialty (RYAN) to $54 from $48 and keeps an Outperform rating on the shares.
Ryan Specialty Holdings Earnings Call Transcript: Q2 2026
Revenue grew 7.2% to $917M in Q2 2026, with strong organic growth and robust performance in casualty and professional lines. Adjusted EBITDA margin declined slightly, while EPS rose 12.1%. Guidance points to high-end mid-single digit organic growth for 2026 amid ongoing competition and pricing headwinds.
Ryan Specialty Holdings Earnings release: Q2 2026
Ryan Specialty Holdings released its Q2 2026 earnings on July 30, 2026, summarizing the period's financial results.